Stoke Therapeutics (STOK) Shares Issued (2022 - 2025)

Stoke Therapeutics has reported Shares Issued over the past 4 years, most recently at -$556000.0 for Q3 2025.

  • For Q3 2025, Shares Issued fell 156.33% year-over-year to -$556000.0; the TTM value through Dec 2025 reached $1.0 million, up 88.35%, while the annual FY2025 figure was $1.0 million, 88.35% up from the prior year.
  • Shares Issued for Q3 2025 was -$556000.0 at Stoke Therapeutics, down from $1.2 million in the prior quarter.
  • Over five years, Shares Issued peaked at $1.2 million in Q2 2025 and troughed at -$623000.0 in Q4 2024.
  • A 4-year average of $171357.1 and a median of $157000.0 in 2023 define the central range for Shares Issued.
  • Biggest five-year swings in Shares Issued: crashed 15675.0% in 2024 and later skyrocketed 1548.78% in 2025.
  • Year by year, Shares Issued stood at $42000.0 in 2022, then plummeted by 90.48% to $4000.0 in 2023, then crashed by 15675.0% to -$623000.0 in 2024, then grew by 10.75% to -$556000.0 in 2025.
  • Business Quant data shows Shares Issued for STOK at -$556000.0 in Q3 2025, $1.2 million in Q2 2025, and $370000.0 in Q1 2025.